| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Satellite Cells, Skeletal Muscle | 24 | 2023 | 124 | 6.230 |
Why?
|
| Muscle, Skeletal | 41 | 2023 | 4931 | 3.410 |
Why?
|
| Stem Cells | 37 | 2022 | 3567 | 3.190 |
Why?
|
| Hematopoietic Stem Cells | 40 | 2019 | 3386 | 2.980 |
Why?
|
| Growth Differentiation Factors | 12 | 2023 | 98 | 2.970 |
Why?
|
| Regeneration | 27 | 2020 | 1485 | 2.130 |
Why?
|
| Muscle Development | 17 | 2023 | 271 | 2.050 |
Why?
|
| Bone Morphogenetic Proteins | 12 | 2023 | 838 | 2.050 |
Why?
|
| Cell Differentiation | 54 | 2023 | 11483 | 1.880 |
Why?
|
| Rhabdomyosarcoma | 9 | 2021 | 382 | 1.510 |
Why?
|
| Rejuvenation | 4 | 2016 | 91 | 1.430 |
Why?
|
| Muscle Fibers, Skeletal | 12 | 2022 | 555 | 1.310 |
Why?
|
| Cell Lineage | 30 | 2016 | 2504 | 1.230 |
Why?
|
| Aging | 23 | 2023 | 8664 | 1.190 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 6 | 2016 | 227 | 1.170 |
Why?
|
| Parabiosis | 11 | 2023 | 65 | 1.100 |
Why?
|
| Cell Proliferation | 27 | 2021 | 10481 | 1.030 |
Why?
|
| Mice, Inbred C57BL | 59 | 2021 | 21827 | 1.000 |
Why?
|
| Mice | 122 | 2023 | 81183 | 0.970 |
Why?
|
| Gene Deletion | 4 | 2019 | 2751 | 0.970 |
Why?
|
| Hematopoiesis | 15 | 2019 | 2072 | 0.960 |
Why?
|
| Animals | 156 | 2023 | 168757 | 0.930 |
Why?
|
| Myostatin | 6 | 2023 | 124 | 0.920 |
Why?
|
| Myoblasts, Skeletal | 3 | 2014 | 76 | 0.890 |
Why?
|
| Flow Cytometry | 22 | 2016 | 5974 | 0.870 |
Why?
|
| Dependovirus | 5 | 2022 | 706 | 0.840 |
Why?
|
| Cell Separation | 15 | 2019 | 1751 | 0.770 |
Why?
|
| Muscular Diseases | 3 | 2016 | 556 | 0.770 |
Why?
|
| Protein Kinase C-delta | 2 | 2018 | 123 | 0.770 |
Why?
|
| Muscle Neoplasms | 4 | 2014 | 139 | 0.740 |
Why?
|
| Paired Box Transcription Factors | 6 | 2021 | 215 | 0.730 |
Why?
|
| Hedgehog Proteins | 3 | 2018 | 783 | 0.730 |
Why?
|
| Stem Cell Niche | 5 | 2018 | 346 | 0.690 |
Why?
|
| Regenerative Medicine | 3 | 2012 | 307 | 0.660 |
Why?
|
| Fucosyltransferases | 6 | 2000 | 119 | 0.650 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 575 | 0.630 |
Why?
|
| E-Selectin | 8 | 2013 | 579 | 0.600 |
Why?
|
| Stem Cell Transplantation | 10 | 2023 | 1620 | 0.600 |
Why?
|
| Signal Transduction | 21 | 2020 | 23403 | 0.580 |
Why?
|
| Bone Marrow | 9 | 2018 | 2948 | 0.570 |
Why?
|
| Fetus | 2 | 2014 | 1880 | 0.550 |
Why?
|
| Myeloid Cells | 3 | 2019 | 810 | 0.550 |
Why?
|
| Cells, Cultured | 30 | 2021 | 19229 | 0.540 |
Why?
|
| Asparagine | 1 | 2015 | 122 | 0.530 |
Why?
|
| Receptors, Notch | 5 | 2014 | 739 | 0.530 |
Why?
|
| Receptors, Cell Surface | 3 | 2015 | 2866 | 0.530 |
Why?
|
| Leukemia, Mast-Cell | 1 | 2015 | 14 | 0.520 |
Why?
|
| Muscular Dystrophy, Duchenne | 3 | 2021 | 256 | 0.520 |
Why?
|
| Cell Movement | 17 | 2019 | 5217 | 0.520 |
Why?
|
| Frameshift Mutation | 2 | 2015 | 399 | 0.510 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2015 | 83 | 0.510 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2015 | 40 | 0.500 |
Why?
|
| Bone Marrow Cells | 11 | 2009 | 2513 | 0.500 |
Why?
|
| Mice, Transgenic | 30 | 2023 | 9734 | 0.490 |
Why?
|
| Chemokine CXCL12 | 2 | 2016 | 464 | 0.490 |
Why?
|
| Genome | 3 | 2019 | 1808 | 0.480 |
Why?
|
| Green Fluorescent Proteins | 12 | 2019 | 2088 | 0.470 |
Why?
|
| Rhabdomyoma | 1 | 2013 | 57 | 0.450 |
Why?
|
| Mastocytosis, Systemic | 1 | 2015 | 100 | 0.450 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 246 | 0.450 |
Why?
|
| GTPase-Activating Proteins | 1 | 2016 | 498 | 0.440 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 913 | 0.430 |
Why?
|
| Adult Stem Cells | 3 | 2012 | 216 | 0.430 |
Why?
|
| Myoblasts | 4 | 2022 | 238 | 0.420 |
Why?
|
| Histiocytic Sarcoma | 1 | 2012 | 44 | 0.420 |
Why?
|
| PAX7 Transcription Factor | 5 | 2018 | 53 | 0.420 |
Why?
|
| Sarcoma | 2 | 2015 | 1897 | 0.420 |
Why?
|
| Muscle Cells | 2 | 2018 | 197 | 0.420 |
Why?
|
| P-Selectin | 8 | 2013 | 600 | 0.410 |
Why?
|
| Gene Expression Regulation | 14 | 2019 | 12072 | 0.410 |
Why?
|
| Adipogenesis | 5 | 2016 | 359 | 0.400 |
Why?
|
| Wound Healing | 7 | 2016 | 2785 | 0.400 |
Why?
|
| Alleles | 3 | 2019 | 6933 | 0.400 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 783 | 0.380 |
Why?
|
| Mice, Knockout | 21 | 2019 | 14557 | 0.380 |
Why?
|
| Induced Pluripotent Stem Cells | 7 | 2015 | 1736 | 0.370 |
Why?
|
| Gene Transfer Techniques | 4 | 2021 | 1224 | 0.370 |
Why?
|
| Immunologic Memory | 6 | 2017 | 1348 | 0.370 |
Why?
|
| Phosphoproteins | 2 | 2016 | 2440 | 0.360 |
Why?
|
| Osteogenesis | 2 | 2014 | 1299 | 0.350 |
Why?
|
| Bone Marrow Transplantation | 10 | 2016 | 2765 | 0.350 |
Why?
|
| Skin | 4 | 2019 | 4364 | 0.350 |
Why?
|
| MyoD Protein | 4 | 2021 | 151 | 0.350 |
Why?
|
| Caloric Restriction | 1 | 2012 | 302 | 0.350 |
Why?
|
| Capsid | 2 | 2022 | 436 | 0.350 |
Why?
|
| Antigens, CD34 | 6 | 2016 | 657 | 0.340 |
Why?
|
| Mice, Inbred Strains | 2 | 2018 | 1827 | 0.330 |
Why?
|
| Integrin alpha Chains | 3 | 2016 | 97 | 0.330 |
Why?
|
| Endothelial Cells | 9 | 2023 | 3479 | 0.330 |
Why?
|
| Blood Cells | 3 | 2010 | 309 | 0.330 |
Why?
|
| DNA-Binding Proteins | 7 | 2016 | 9648 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2016 | 2503 | 0.320 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2008 | 140 | 0.310 |
Why?
|
| NF-kappa B | 1 | 2016 | 2499 | 0.310 |
Why?
|
| Antigens, Ly | 5 | 2011 | 291 | 0.310 |
Why?
|
| DNA Damage | 2 | 2015 | 2432 | 0.310 |
Why?
|
| Mice, Inbred mdx | 2 | 2019 | 90 | 0.310 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1422 | 0.310 |
Why?
|
| Energy Metabolism | 3 | 2020 | 2899 | 0.300 |
Why?
|
| Mast Cells | 1 | 2015 | 1544 | 0.300 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1222 | 0.300 |
Why?
|
| Membrane Proteins | 7 | 2016 | 7880 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 1 | 2016 | 1061 | 0.290 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 6 | 2016 | 648 | 0.290 |
Why?
|
| Genes, Reporter | 5 | 2019 | 1547 | 0.290 |
Why?
|
| RNA-Binding Proteins | 2 | 2016 | 1903 | 0.280 |
Why?
|
| Colony-Forming Units Assay | 3 | 2014 | 356 | 0.280 |
Why?
|
| Autophagy | 1 | 2014 | 1300 | 0.280 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2015 | 4386 | 0.280 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2021 | 2942 | 0.280 |
Why?
|
| Multipotent Stem Cells | 2 | 2015 | 186 | 0.280 |
Why?
|
| Integrin alpha2 | 1 | 2005 | 40 | 0.270 |
Why?
|
| Osteoblasts | 2 | 2010 | 1166 | 0.270 |
Why?
|
| Apoptosis | 6 | 2021 | 9727 | 0.260 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2019 | 3617 | 0.260 |
Why?
|
| Gene Expression Profiling | 15 | 2021 | 9438 | 0.260 |
Why?
|
| Cell Adhesion | 9 | 2010 | 3144 | 0.260 |
Why?
|
| Ovum | 1 | 2006 | 189 | 0.260 |
Why?
|
| Ovulation | 1 | 2006 | 189 | 0.260 |
Why?
|
| Precancerous Conditions | 1 | 2012 | 975 | 0.260 |
Why?
|
| ras Proteins | 3 | 2018 | 1060 | 0.250 |
Why?
|
| Antigens, CD | 8 | 2016 | 4026 | 0.250 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 2 | 2014 | 41 | 0.240 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 13 | 2014 | 5442 | 0.240 |
Why?
|
| Phenotype | 10 | 2019 | 16365 | 0.230 |
Why?
|
| Wnt Proteins | 1 | 2008 | 721 | 0.230 |
Why?
|
| Genetic Engineering | 3 | 2019 | 951 | 0.230 |
Why?
|
| Disease Models, Animal | 17 | 2021 | 18029 | 0.230 |
Why?
|
| Myogenic Regulatory Factor 5 | 2 | 2014 | 25 | 0.220 |
Why?
|
| Mitochondria | 2 | 2014 | 3520 | 0.220 |
Why?
|
| Genetic Testing | 1 | 2015 | 3444 | 0.210 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2021 | 1581 | 0.210 |
Why?
|
| Fibroblasts | 4 | 2018 | 4161 | 0.210 |
Why?
|
| Humans | 80 | 2021 | 744343 | 0.210 |
Why?
|
| Homeostasis | 3 | 2016 | 3340 | 0.210 |
Why?
|
| Organ Specificity | 8 | 2019 | 2008 | 0.210 |
Why?
|
| Ligands | 7 | 2019 | 3282 | 0.210 |
Why?
|
| Cell Cycle | 5 | 2015 | 2967 | 0.210 |
Why?
|
| Immunoglobulins | 1 | 2005 | 881 | 0.200 |
Why?
|
| Leukocytes | 3 | 2006 | 2043 | 0.200 |
Why?
|
| Adipocytes, Brown | 2 | 2014 | 144 | 0.200 |
Why?
|
| RNA, Messenger | 9 | 2015 | 13033 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2016 | 4751 | 0.190 |
Why?
|
| Oocytes | 1 | 2006 | 1187 | 0.190 |
Why?
|
| Myocardium | 6 | 2017 | 4776 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 7 | 2016 | 2505 | 0.190 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2020 | 38 | 0.190 |
Why?
|
| Genes, fos | 1 | 2021 | 183 | 0.190 |
Why?
|
| Thiazolidines | 1 | 2020 | 74 | 0.190 |
Why?
|
| Integrases | 2 | 2023 | 533 | 0.190 |
Why?
|
| Semen | 1 | 2023 | 316 | 0.190 |
Why?
|
| Immune System | 2 | 2019 | 805 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2021 | 8428 | 0.190 |
Why?
|
| Directed Molecular Evolution | 1 | 2021 | 160 | 0.190 |
Why?
|
| Integrins | 2 | 2021 | 846 | 0.190 |
Why?
|
| Transcription, Genetic | 6 | 2015 | 7722 | 0.180 |
Why?
|
| Forkhead Transcription Factors | 4 | 2015 | 1613 | 0.180 |
Why?
|
| Genetic Vectors | 2 | 2022 | 3420 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2016 | 3336 | 0.180 |
Why?
|
| Clone Cells | 3 | 2012 | 1692 | 0.180 |
Why?
|
| Cat Diseases | 1 | 2019 | 35 | 0.180 |
Why?
|
| Insulin Resistance | 4 | 2020 | 3864 | 0.170 |
Why?
|
| Muscles | 6 | 2018 | 1614 | 0.170 |
Why?
|
| T-Lymphocytes, Regulatory | 4 | 2019 | 2988 | 0.170 |
Why?
|
| Interleukin-12 | 2 | 1999 | 579 | 0.170 |
Why?
|
| Vaccinia | 2 | 2017 | 76 | 0.170 |
Why?
|
| Bone Development | 1 | 2023 | 483 | 0.170 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2019 | 49 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2013 | 4479 | 0.170 |
Why?
|
| Thymus Gland | 2 | 2015 | 1267 | 0.170 |
Why?
|
| N-Acetylglucosaminyltransferases | 3 | 2014 | 171 | 0.170 |
Why?
|
| Endothelium, Vascular | 6 | 2014 | 4456 | 0.160 |
Why?
|
| Selectins | 1 | 1998 | 102 | 0.160 |
Why?
|
| Superantigens | 1 | 1998 | 129 | 0.160 |
Why?
|
| Glycoproteins | 2 | 2013 | 2263 | 0.160 |
Why?
|
| Zebrafish | 3 | 2023 | 2994 | 0.160 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2016 | 707 | 0.160 |
Why?
|
| Myocytes, Cardiac | 3 | 2019 | 1637 | 0.160 |
Why?
|
| Transgenes | 5 | 2021 | 1009 | 0.160 |
Why?
|
| Interleukin-4 | 2 | 1999 | 1147 | 0.160 |
Why?
|
| Mammals | 3 | 2023 | 1143 | 0.160 |
Why?
|
| Immunity | 1 | 2014 | 1012 | 0.160 |
Why?
|
| Cyclophosphamide | 4 | 2008 | 2242 | 0.160 |
Why?
|
| Mutation | 5 | 2019 | 29786 | 0.160 |
Why?
|
| Vaccinia virus | 2 | 2017 | 349 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 3 | 2023 | 2007 | 0.160 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 186 | 0.150 |
Why?
|
| Tryptophan | 1 | 2019 | 478 | 0.150 |
Why?
|
| Small Molecule Libraries | 2 | 2020 | 720 | 0.150 |
Why?
|
| DNA, Neoplasm | 2 | 2013 | 1758 | 0.150 |
Why?
|
| Iodide Peroxidase | 1 | 2019 | 293 | 0.150 |
Why?
|
| Immunohistochemistry | 7 | 2015 | 11366 | 0.150 |
Why?
|
| Sodium Salicylate | 1 | 2016 | 19 | 0.150 |
Why?
|
| Male | 34 | 2023 | 350118 | 0.150 |
Why?
|
| Neoplasm Transplantation | 5 | 2014 | 2085 | 0.140 |
Why?
|
| Urogenital Neoplasms | 1 | 2018 | 137 | 0.140 |
Why?
|
| Leukemia | 4 | 2013 | 1511 | 0.140 |
Why?
|
| Muscular Dystrophies | 3 | 2013 | 393 | 0.140 |
Why?
|
| Oligosaccharides | 1 | 1998 | 414 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2018 | 2109 | 0.140 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2016 | 111 | 0.140 |
Why?
|
| HMGA2 Protein | 1 | 2016 | 123 | 0.140 |
Why?
|
| Ketoglutaric Acids | 1 | 2016 | 78 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2013 | 546 | 0.130 |
Why?
|
| Gene Expression | 4 | 2019 | 7799 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 1285 | 0.130 |
Why?
|
| Ischemic Preconditioning | 1 | 2016 | 92 | 0.130 |
Why?
|
| Cell Line, Tumor | 10 | 2021 | 16689 | 0.130 |
Why?
|
| Models, Immunological | 2 | 2015 | 527 | 0.130 |
Why?
|
| Central Nervous System | 2 | 2013 | 1357 | 0.130 |
Why?
|
| Bacterial Secretion Systems | 1 | 2015 | 38 | 0.130 |
Why?
|
| Homozygote | 1 | 2019 | 1785 | 0.130 |
Why?
|
| Immunophenotyping | 3 | 2021 | 1880 | 0.130 |
Why?
|
| Female | 29 | 2023 | 380194 | 0.130 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2010 | 689 | 0.120 |
Why?
|
| Cell Transplantation | 3 | 2006 | 477 | 0.120 |
Why?
|
| Granulation Tissue | 2 | 2016 | 93 | 0.120 |
Why?
|
| Bronchioles | 1 | 2014 | 25 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2009 | 776 | 0.120 |
Why?
|
| Radiation Chimera | 3 | 2013 | 223 | 0.120 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2016 | 563 | 0.120 |
Why?
|
| Epitopes | 2 | 1998 | 2571 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 2019 | 1169 | 0.120 |
Why?
|
| Ossification, Heterotopic | 1 | 2016 | 239 | 0.120 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 350 | 0.120 |
Why?
|
| Muscular Dystrophy, Animal | 2 | 2018 | 90 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 2 | 2015 | 481 | 0.120 |
Why?
|
| Interferon Type I | 1 | 2017 | 542 | 0.120 |
Why?
|
| Schwann Cells | 1 | 2014 | 195 | 0.110 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2014 | 102 | 0.110 |
Why?
|
| Heparitin Sulfate | 1 | 2014 | 225 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 1376 | 0.110 |
Why?
|
| Mice, SCID | 3 | 2014 | 2716 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2000 | 1526 | 0.110 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 3647 | 0.110 |
Why?
|
| Hepatocytes | 3 | 2013 | 1211 | 0.110 |
Why?
|
| Chemotaxis | 2 | 2008 | 607 | 0.110 |
Why?
|
| Bacterial Toxins | 1 | 1998 | 931 | 0.110 |
Why?
|
| Graft Survival | 5 | 2014 | 3737 | 0.110 |
Why?
|
| RNA | 1 | 2023 | 2749 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2019 | 851 | 0.110 |
Why?
|
| Mice, Inbred NOD | 3 | 2014 | 1878 | 0.110 |
Why?
|
| Review Literature as Topic | 1 | 2015 | 336 | 0.110 |
Why?
|
| Cluster Analysis | 4 | 2015 | 2715 | 0.110 |
Why?
|
| Chimera | 3 | 2003 | 485 | 0.110 |
Why?
|
| Lymphocyte Activation | 2 | 2000 | 5524 | 0.110 |
Why?
|
| Models, Biological | 8 | 2015 | 9583 | 0.100 |
Why?
|
| Erythropoiesis | 1 | 2016 | 705 | 0.100 |
Why?
|
| Luciferases | 5 | 2017 | 733 | 0.100 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2012 | 64 | 0.100 |
Why?
|
| Diabetic Foot | 1 | 2016 | 355 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2018 | 2634 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2015 | 1676 | 0.100 |
Why?
|
| Viral Vaccines | 1 | 2017 | 636 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 726 | 0.100 |
Why?
|
| Cell Count | 3 | 2011 | 1856 | 0.100 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 379 | 0.100 |
Why?
|
| Genes, p53 | 1 | 2013 | 755 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1526 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 2 | 2013 | 1632 | 0.100 |
Why?
|
| Primary Myelofibrosis | 1 | 2013 | 215 | 0.100 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 390 | 0.100 |
Why?
|
| Galactose | 1 | 2012 | 306 | 0.100 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 675 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 3 | 2006 | 2635 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1114 | 0.090 |
Why?
|
| Myogenin | 1 | 2010 | 58 | 0.090 |
Why?
|
| Transcription Factors | 4 | 2019 | 12208 | 0.090 |
Why?
|
| Hematopoietic System | 2 | 2008 | 109 | 0.090 |
Why?
|
| Muscle Proteins | 1 | 2016 | 1159 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2019 | 1265 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2017 | 8436 | 0.090 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2010 | 106 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2009 | 5751 | 0.090 |
Why?
|
| Macrophages | 2 | 2016 | 5655 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 1996 | 1602 | 0.090 |
Why?
|
| Cardiomegaly | 1 | 2013 | 620 | 0.090 |
Why?
|
| Oncogenes | 2 | 2014 | 1265 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2019 | 2575 | 0.090 |
Why?
|
| Intra-Abdominal Fat | 1 | 2015 | 591 | 0.090 |
Why?
|
| Embryo Research | 1 | 2010 | 60 | 0.090 |
Why?
|
| Exons | 1 | 2015 | 2437 | 0.090 |
Why?
|
| MicroRNAs | 2 | 2016 | 3752 | 0.090 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2009 | 19 | 0.090 |
Why?
|
| Blood Vessels | 2 | 2006 | 1125 | 0.090 |
Why?
|
| Oligodendroglia | 1 | 2013 | 517 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2015 | 5179 | 0.090 |
Why?
|
| T-Lymphocytes | 4 | 2017 | 10180 | 0.090 |
Why?
|
| Natural Killer T-Cells | 1 | 2012 | 316 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2013 | 805 | 0.090 |
Why?
|
| Muscle Contraction | 2 | 2019 | 1240 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 705 | 0.090 |
Why?
|
| Computational Biology | 4 | 2021 | 3521 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2014 | 6544 | 0.080 |
Why?
|
| Body Weight | 1 | 2020 | 4669 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2015 | 1538 | 0.080 |
Why?
|
| Stromal Cells | 1 | 2014 | 1355 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 4186 | 0.080 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2012 | 259 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 6 | 2023 | 5867 | 0.080 |
Why?
|
| Benzamides | 1 | 2014 | 1379 | 0.080 |
Why?
|
| Nerve Regeneration | 1 | 2014 | 788 | 0.080 |
Why?
|
| Cell Line | 5 | 2020 | 15997 | 0.080 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 1375 | 0.080 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2009 | 236 | 0.080 |
Why?
|
| Glycosyltransferases | 2 | 1998 | 113 | 0.080 |
Why?
|
| Adipose Tissue, White | 1 | 2010 | 351 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1119 | 0.080 |
Why?
|
| Myelin Sheath | 1 | 2012 | 652 | 0.080 |
Why?
|
| Embryonic Induction | 1 | 2008 | 149 | 0.080 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2010 | 434 | 0.080 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 378 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2014 | 838 | 0.080 |
Why?
|
| Transplantation Conditioning | 1 | 2014 | 1598 | 0.080 |
Why?
|
| Antigens, Differentiation | 2 | 2008 | 927 | 0.080 |
Why?
|
| Adaptation, Biological | 1 | 2008 | 153 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2014 | 2382 | 0.070 |
Why?
|
| Immunologic Surveillance | 1 | 2007 | 93 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2649 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2008 | 365 | 0.070 |
Why?
|
| Myeloproliferative Disorders | 1 | 2013 | 606 | 0.070 |
Why?
|
| Dystrophin | 1 | 2008 | 285 | 0.070 |
Why?
|
| Rats | 6 | 2016 | 24260 | 0.070 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 851 | 0.070 |
Why?
|
| Cell Fusion | 2 | 2004 | 297 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2077 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2020 | 5535 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.070 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2008 | 272 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2014 | 1341 | 0.070 |
Why?
|
| Islets of Langerhans | 1 | 2013 | 1352 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2019 | 1655 | 0.070 |
Why?
|
| Age Factors | 4 | 2019 | 18370 | 0.070 |
Why?
|
| Lymphatic System | 1 | 2007 | 253 | 0.070 |
Why?
|
| Dendritic Cells | 2 | 2008 | 2725 | 0.070 |
Why?
|
| Immunoassay | 1 | 2010 | 752 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 4 | 2004 | 9274 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 1788 | 0.070 |
Why?
|
| Membrane Glycoproteins | 4 | 2013 | 3768 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 430 | 0.070 |
Why?
|
| Follistatin | 2 | 2017 | 141 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2012 | 1838 | 0.070 |
Why?
|
| COS Cells | 2 | 1998 | 1161 | 0.070 |
Why?
|
| Heme Oxygenase-1 | 1 | 2008 | 381 | 0.070 |
Why?
|
| Complement C3 | 1 | 2007 | 461 | 0.070 |
Why?
|
| Genetic Techniques | 1 | 2008 | 435 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 891 | 0.060 |
Why?
|
| Blood | 1 | 2007 | 598 | 0.060 |
Why?
|
| Microglia | 1 | 2013 | 1266 | 0.060 |
Why?
|
| H-2 Antigens | 1 | 2005 | 366 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1692 | 0.060 |
Why?
|
| DNA Repair | 1 | 2014 | 2046 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13695 | 0.060 |
Why?
|
| Infant | 3 | 2018 | 35136 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 1438 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2013 | 2969 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2012 | 1349 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2010 | 1534 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2016 | 1116 | 0.060 |
Why?
|
| Brain Neoplasms | 4 | 2006 | 8863 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2014 | 2925 | 0.060 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2013 | 906 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 2731 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 1 | 2018 | 2734 | 0.060 |
Why?
|
| Th1 Cells | 2 | 1999 | 1057 | 0.060 |
Why?
|
| Protein Transport | 2 | 2023 | 1988 | 0.060 |
Why?
|
| Th2 Cells | 2 | 1999 | 1061 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 2916 | 0.060 |
Why?
|
| Cell Division | 3 | 2015 | 4568 | 0.060 |
Why?
|
| Cytokines | 2 | 2016 | 7322 | 0.060 |
Why?
|
| Testosterone | 1 | 2014 | 2420 | 0.060 |
Why?
|
| Autoantibodies | 2 | 2012 | 2035 | 0.060 |
Why?
|
| Telomerase | 1 | 2008 | 730 | 0.060 |
Why?
|
| Insulin | 3 | 2016 | 6580 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2011 | 1058 | 0.060 |
Why?
|
| Proteomics | 1 | 2016 | 3638 | 0.060 |
Why?
|
| Embryonic Development | 1 | 2008 | 711 | 0.060 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 853 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2016 | 675 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2005 | 594 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3690 | 0.050 |
Why?
|
| Intestine, Large | 1 | 2002 | 71 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2015 | 4217 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2013 | 3920 | 0.050 |
Why?
|
| Nucleoproteins | 1 | 2023 | 115 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6171 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 7 | 2 | 2014 | 112 | 0.050 |
Why?
|
| beta Catenin | 1 | 2008 | 1059 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2013 | 2726 | 0.050 |
Why?
|
| Pyridines | 1 | 2014 | 2825 | 0.050 |
Why?
|
| Monocytes | 2 | 2012 | 2596 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2010 | 2740 | 0.050 |
Why?
|
| Obesity | 2 | 2015 | 12745 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 13815 | 0.050 |
Why?
|
| Langerhans Cells | 1 | 2002 | 173 | 0.050 |
Why?
|
| Arthritis | 1 | 2007 | 659 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2017 | 2256 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 2015 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 2699 | 0.050 |
Why?
|
| Culture Media, Conditioned | 2 | 2013 | 537 | 0.050 |
Why?
|
| Neovascularization, Physiologic | 1 | 2009 | 1351 | 0.050 |
Why?
|
| Ovary | 1 | 2006 | 981 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 11727 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 3848 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2021 | 66 | 0.050 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1708 | 0.050 |
Why?
|
| Cell Transdifferentiation | 2 | 2013 | 172 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1294 | 0.050 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2021 | 102 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2014 | 5021 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 2017 | 3129 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2008 | 1403 | 0.050 |
Why?
|
| Collagen | 1 | 2009 | 2689 | 0.050 |
Why?
|
| Enzyme Induction | 1 | 2000 | 475 | 0.050 |
Why?
|
| Awards and Prizes | 1 | 2005 | 375 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 6622 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2016 | 3508 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2013 | 2540 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4204 | 0.040 |
Why?
|
| Epigenomics | 2 | 2019 | 903 | 0.040 |
Why?
|
| Neuroglia | 1 | 2005 | 927 | 0.040 |
Why?
|
| Body Patterning | 1 | 2004 | 626 | 0.040 |
Why?
|
| Furans | 1 | 2020 | 194 | 0.040 |
Why?
|
| Brain | 5 | 2023 | 26385 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 669 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2021 | 915 | 0.040 |
Why?
|
| Capsid Proteins | 1 | 2022 | 479 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 3462 | 0.040 |
Why?
|
| Phytohemagglutinins | 1 | 1998 | 170 | 0.040 |
Why?
|
| Protein Binding | 3 | 2019 | 9386 | 0.040 |
Why?
|
| Chromatin | 2 | 2022 | 2934 | 0.040 |
Why?
|
| Carbazoles | 1 | 2020 | 226 | 0.040 |
Why?
|
| Aged | 6 | 2016 | 163280 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 528 | 0.040 |
Why?
|
| Thermogenesis | 2 | 2014 | 435 | 0.040 |
Why?
|
| Transfection | 2 | 1997 | 5892 | 0.040 |
Why?
|
| Neurosurgery | 1 | 2005 | 643 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2183 | 0.040 |
Why?
|
| Cats | 1 | 2019 | 998 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3064 | 0.040 |
Why?
|
| CHO Cells | 1 | 2000 | 1406 | 0.040 |
Why?
|
| Chemokines | 1 | 2002 | 970 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 2849 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 57776 | 0.040 |
Why?
|
| HL-60 Cells | 1 | 1998 | 365 | 0.040 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1998 | 177 | 0.040 |
Why?
|
| Organ Size | 2 | 2014 | 2252 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 414 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2017 | 226 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 697 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 2019 | 494 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2008 | 4851 | 0.040 |
Why?
|
| Structural Homology, Protein | 1 | 2017 | 91 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 19905 | 0.040 |
Why?
|
| Enterotoxins | 1 | 1998 | 368 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 2 | 2009 | 130 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2006 | 6314 | 0.040 |
Why?
|
| Species Specificity | 1 | 2021 | 2478 | 0.040 |
Why?
|
| Cricetinae | 1 | 2000 | 2472 | 0.040 |
Why?
|
| Lung | 2 | 2008 | 9856 | 0.040 |
Why?
|
| Amino Acids | 1 | 2023 | 1736 | 0.040 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1997 | 189 | 0.040 |
Why?
|
| Smad Proteins | 1 | 2017 | 162 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 2019 | 0.040 |
Why?
|
| Genotype | 2 | 2016 | 12951 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 1586 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2021 | 970 | 0.030 |
Why?
|
| Liver | 3 | 2022 | 7474 | 0.030 |
Why?
|
| Ligaments | 1 | 2016 | 128 | 0.030 |
Why?
|
| Activin Receptors, Type I | 1 | 2016 | 142 | 0.030 |
Why?
|
| Kynurenic Acid | 1 | 2016 | 46 | 0.030 |
Why?
|
| Follistatin-Related Proteins | 1 | 2016 | 48 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2017 | 5456 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2002 | 1241 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2014 | 4740 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 893 | 0.030 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 3036 | 0.030 |
Why?
|
| Binding Sites | 2 | 2019 | 6114 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2016 | 3689 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 314 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2005 | 4217 | 0.030 |
Why?
|
| Heart Failure | 1 | 2019 | 10900 | 0.030 |
Why?
|
| Thyroxine | 1 | 2019 | 667 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 418 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2017 | 711 | 0.030 |
Why?
|
| Genes, cdc | 1 | 2015 | 116 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 6386 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2018 | 41006 | 0.030 |
Why?
|
| Joints | 1 | 2016 | 326 | 0.030 |
Why?
|
| Algorithms | 2 | 2013 | 13881 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 661 | 0.030 |
Why?
|
| Horses | 1 | 2015 | 304 | 0.030 |
Why?
|
| Receptors, CCR2 | 2 | 2008 | 212 | 0.030 |
Why?
|
| Fertility | 1 | 2019 | 781 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 2019 | 2958 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2017 | 1420 | 0.030 |
Why?
|
| Dimerization | 1 | 2016 | 893 | 0.030 |
Why?
|
| Radiation | 1 | 2014 | 49 | 0.030 |
Why?
|
| Prognosis | 1 | 2015 | 29063 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 2016 | 157 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1782 | 0.030 |
Why?
|
| Shigella flexneri | 1 | 2015 | 132 | 0.030 |
Why?
|
| Cadmium Chloride | 1 | 2013 | 9 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2010 | 3445 | 0.030 |
Why?
|
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 2013 | 8 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 2013 | 83 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2014 | 96 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 162 | 0.030 |
Why?
|
| Clodronic Acid | 1 | 2013 | 60 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2023 | 4286 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2014 | 241 | 0.030 |
Why?
|
| Culture Media | 1 | 2015 | 908 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2013 | 25625 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 2148 | 0.030 |
Why?
|
| Transplantation Chimera | 2 | 2006 | 612 | 0.030 |
Why?
|
| Culture Techniques | 1 | 2013 | 554 | 0.030 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2013 | 92 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2014 | 1157 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 2014 | 200 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2013 | 205 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 1437 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1660 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 1682 | 0.030 |
Why?
|
| Syndecans | 1 | 2012 | 79 | 0.030 |
Why?
|
| Myelin Proteins | 1 | 2013 | 215 | 0.030 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2012 | 48 | 0.030 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2016 | 476 | 0.030 |
Why?
|
| Neurons | 3 | 2015 | 9338 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2014 | 569 | 0.030 |
Why?
|
| Thrombospondin 1 | 1 | 2014 | 250 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2016 | 687 | 0.030 |
Why?
|
| Child | 3 | 2018 | 77709 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 1341 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2013 | 455 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2017 | 2011 | 0.030 |
Why?
|
| Adult | 7 | 2018 | 214055 | 0.030 |
Why?
|
| Spleen | 3 | 2004 | 2362 | 0.030 |
Why?
|
| Antigens | 2 | 2010 | 1466 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2216 | 0.030 |
Why?
|
| Neutrophils | 1 | 2014 | 3719 | 0.030 |
Why?
|
| Histocompatibility Antigens | 1 | 2013 | 471 | 0.030 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 381 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 2752 | 0.030 |
Why?
|
| Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
| Interleukin-2 | 1 | 1998 | 1904 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 553 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 2839 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 337 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 6538 | 0.020 |
Why?
|
| Glycolysis | 1 | 2015 | 827 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2013 | 342 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2013 | 225 | 0.020 |
Why?
|
| Germ Cells | 1 | 2015 | 631 | 0.020 |
Why?
|
| Virulence | 1 | 2015 | 1333 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2014 | 607 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2013 | 354 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 1998 | 1988 | 0.020 |
Why?
|
| Middle Aged | 5 | 2016 | 213383 | 0.020 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 541 | 0.020 |
Why?
|
| Biological Transport | 1 | 2015 | 2118 | 0.020 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 4665 | 0.020 |
Why?
|
| Embryoid Bodies | 1 | 2010 | 67 | 0.020 |
Why?
|
| Genes, abl | 1 | 2010 | 72 | 0.020 |
Why?
|
| Flavonoids | 1 | 2013 | 443 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2016 | 18111 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 588 | 0.020 |
Why?
|
| Plasmids | 1 | 2015 | 2307 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2014 | 1252 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 767 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2013 | 1472 | 0.020 |
Why?
|
| Trans-Activators | 2 | 2013 | 2924 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2009 | 32 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2013 | 1185 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 11725 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2005 | 3481 | 0.020 |
Why?
|
| U937 Cells | 1 | 2009 | 268 | 0.020 |
Why?
|
| Calgranulin A | 1 | 2009 | 79 | 0.020 |
Why?
|
| Models, Animal | 1 | 2016 | 2171 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3870 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2013 | 846 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 4149 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2016 | 3846 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2015 | 3128 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 1375 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 1420 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 1549 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2015 | 1359 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 4011 | 0.020 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2013 | 745 | 0.020 |
Why?
|
| Thoracic Duct | 1 | 2007 | 63 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 713 | 0.020 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2013 | 859 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 2012 | 0.020 |
Why?
|
| Heparin | 1 | 2014 | 1637 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2010 | 592 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 1312 | 0.020 |
Why?
|
| Ischemia | 1 | 2016 | 1907 | 0.020 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2007 | 122 | 0.020 |
Why?
|
| Kidney | 1 | 2002 | 7186 | 0.020 |
Why?
|
| Zebrafish Proteins | 1 | 2013 | 1005 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 3670 | 0.020 |
Why?
|
| Time Factors | 4 | 2012 | 40075 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6365 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 944 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1202 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2013 | 2126 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 6473 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 1100 | 0.020 |
Why?
|
| Young Adult | 3 | 2018 | 56430 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 17446 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2011 | 1725 | 0.020 |
Why?
|
| Testis | 1 | 2008 | 803 | 0.020 |
Why?
|
| Base Sequence | 2 | 2009 | 12797 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2005 | 5788 | 0.020 |
Why?
|
| Angiogenic Proteins | 1 | 2004 | 104 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2012 | 1881 | 0.010 |
Why?
|
| Stem Cell Factor | 1 | 2004 | 219 | 0.010 |
Why?
|
| Survival Rate | 1 | 2018 | 12788 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1405 | 0.010 |
Why?
|
| Liver Regeneration | 1 | 2005 | 210 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2008 | 1619 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2012 | 3206 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2016 | 2788 | 0.010 |
Why?
|
| Dietary Fats | 1 | 2011 | 2017 | 0.010 |
Why?
|
| Birth Weight | 1 | 2011 | 2069 | 0.010 |
Why?
|
| Heart | 1 | 2016 | 4467 | 0.010 |
Why?
|
| Actins | 1 | 2010 | 2121 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2011 | 1609 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13284 | 0.010 |
Why?
|
| United States | 1 | 2010 | 69872 | 0.010 |
Why?
|
| Cranial Irradiation | 1 | 2005 | 401 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2004 | 422 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 8301 | 0.010 |
Why?
|
| Granulocytes | 1 | 2004 | 548 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5882 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2013 | 3023 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2005 | 669 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2003 | 405 | 0.010 |
Why?
|
| Body Composition | 1 | 2011 | 2401 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2001 | 101 | 0.010 |
Why?
|
| Neoplasms | 2 | 2008 | 21683 | 0.010 |
Why?
|
| Metaphase | 1 | 2001 | 151 | 0.010 |
Why?
|
| Pregnancy | 1 | 2023 | 29144 | 0.010 |
Why?
|
| Blood Circulation | 1 | 2001 | 251 | 0.010 |
Why?
|
| Weight Loss | 1 | 2012 | 2622 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 10252 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 2002 | 608 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2001 | 964 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3505 | 0.010 |
Why?
|
| Genome, Human | 1 | 2012 | 4420 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 5853 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2014 | 4599 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 675 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 1970 | 0.010 |
Why?
|
| Cyclins | 1 | 2001 | 603 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2011 | 3188 | 0.010 |
Why?
|
| Adolescent | 2 | 2018 | 85781 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2010 | 3743 | 0.010 |
Why?
|
| Rheology | 1 | 1999 | 345 | 0.010 |
Why?
|
| Cell Communication | 1 | 2005 | 1621 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 3002 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 1060 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 2892 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2013 | 8554 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 3079 | 0.010 |
Why?
|
| Hemorheology | 1 | 1997 | 145 | 0.010 |
Why?
|
| Cognition | 1 | 2014 | 6770 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39050 | 0.010 |
Why?
|
| Acute Disease | 1 | 2006 | 7149 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1999 | 645 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1703 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 11031 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1997 | 394 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 12261 | 0.010 |
Why?
|
| DNA Replication | 1 | 2001 | 1399 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2006 | 2957 | 0.010 |
Why?
|
| Brain Injuries | 1 | 2005 | 2025 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3772 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 40561 | 0.010 |
Why?
|
| Software | 1 | 2005 | 4443 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2002 | 2133 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15295 | 0.010 |
Why?
|
| Glioma | 1 | 2004 | 3401 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 63114 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 72290 | 0.000 |
Why?
|
| Inflammation | 1 | 2002 | 10638 | 0.000 |
Why?
|
| Granuloma, Lethal Midline | 1 | 1954 | 4 | 0.000 |
Why?
|
| Granuloma | 1 | 1954 | 319 | 0.000 |
Why?
|
| Disease | 1 | 1954 | 680 | 0.000 |
Why?
|
| Face | 1 | 1954 | 994 | 0.000 |
Why?
|